117- Cai C, Teng L, Vu D, He JQ, Guo Y, Li Q, Tang XL, et al. The heme oxygenase 1 inducer
(CoPP) protects human cardiac stem cells against apoptosis through activation of the extracel-
lular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol
Chem. 2012;287:33720–32. - Waring CD, Vicinanza C, Papalamprou A, Smith AJ, Purushothaman S, Goldspink DF, et al.
The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem
cell. Eur Heart J. 2014;35(39):2722–31. - Ellison GM, Torella D, Dellegrottaglie S, Perez-Martinez C, Perez de Prado A, Vicinanza C,
et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte
growth factor intracoronary injection fosters survival and regeneration of the infarcted pig
heart. J Am Coll Cardiol. 2011;58:977–86. - Koudstaal S, Bastings MM, Feyen DA, Waring CD, van Slochteren FJ, Dankers PY, et al.
Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endog-
enous cardiac repair in the chronic infarcted pig heart. J Cardiovasc Transl Res. 2014;7:
232–41. - Jackson R, Tilokee EL, Latham N, Mount S, Rafatian G, Strydhorst J, et al. Paracrine engi-
neering of human cardiac stem cells with insulin-like growth factor 1 enhances myocardial
repair. J Am Heart Assoc. 2015;4:e002104. - Russell JL, Goetsch SC, Aguilar HR, Frantz DE, Schneider JW. Targeting native adult heart
progenitors with cardiogenic small-molecules. ACS Chem Biol. 2012;7:1067–76. - Koh GY, Klug MG, Soonpaa MH, Field LJ. Differentiation and long-term survival of C2C12
myoblast grafts in heart. J Clin Invest. 1993;92:1548–54. - Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzeźniczak J, Rozwadowska N,
et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myo-
cardial injury: phase I clinical study with 12 months of follow-up. Am Heart J. 2004;148(3):
531–7. - Gavira JJ, Herreros J, Perez A, Garcia-Velloso MJ, Barba J, Martin-Herrero F, et al. Autologous
skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year fol-
low- up. J Thorac Cardiovasc Surg. 2006;131:799–804. - Li RK, Mickle DA, Weisel RD, Mohabeer MK, Zhang J, Rao V, et al. Natural history of fetal
rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation. 1997;96:
179–86. - Sakai T, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, et al. Fetal cell transplantation: a
comparison of three cell types. J Thorac Cardiovasc Surg. 1999;118:715–24. - Min JY, Sullivan MF, Yang Y, Zhang JP, Converso KL, Morgan JP, et al. Significant improve-
ment of heart function by cotransplantation of human mesenchymal stem cells and fetal car-
diomyocytes in postinfarcted pigs. Ann Thorac Surg. 2002;74:1568–75. - Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells
regenerate infarcted myocardium. Nature. 2001;410:701–5. - Balsam LB, Robbins RC. Haematopoietic stem cells and repair of the ischaemic heart. Clin Sci
(Lond). 2005;109:483–92. - Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, et al. Enhanced
effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to
reduce infarct size and to restore cardiac function after myocardial infarction. Circulation.
2013;127:213–23. - Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative
progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7. - Kalka C, Tehrani H, Laudenberg B, Vale PR, Isner JM, Asahara T, et al. VEGF gene transfer
mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann
Thorac Surg. 2000;70:829–34. - Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, et al. Therapeutic
potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation.
2001;103:634–7.
7 The Emerging Role of Cardiac Stem Cells in Cardiac Regeneration